MJNA Stock Overview
An investment holding company, operates in the cannabinoid-based nutraceutical industry. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Medical Marijuana, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0006 |
| 52 Week High | US$0.0061 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | -33.33% |
| 3 Month Change | -45.45% |
| 1 Year Change | -89.09% |
| 33 Year Change | -97.44% |
| 5 Year Change | -97.74% |
| Change since IPO | -98.80% |
Recent News & Updates
Recent updates
Shareholder Returns
| MJNA | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 2.2% |
| 1Y | -89.1% | 2.1% | 31.6% |
Return vs Industry: MJNA underperformed the US Healthcare industry which returned 2.1% over the past year.
Return vs Market: MJNA underperformed the US Market which returned 31.6% over the past year.
Price Volatility
| MJNA volatility | |
|---|---|
| MJNA Average Weekly Movement | 22.6% |
| Healthcare Industry Average Movement | 6.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MJNA's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: MJNA's weekly volatility (23%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | Timothy Scott | www.medicalmarijuanainc.com |
Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. It focuses on the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol (CBD) and other products containing CBD-rich hemp oil; treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products; and nonpsychoactive cannabidiol products. The company is also involved in the research and development of new therapeutic agents that are designed to reduce oxidative stress and act as immuno-modulators and neuroprotectants; dietary supplements, skin care products, and prescription-based hemp oil under the Kannaway and HempMeds brands; and proprietary testing, genetics, labeling and packaging, tracking, and production and standardization methods for the medicinal cannabinoid industry.
Medical Marijuana, Inc. Fundamentals Summary
| MJNA fundamental statistics | |
|---|---|
| Market cap | US$3.51m |
| Earnings (TTM) | US$8.80m |
| Revenue (TTM) | US$58.98m |
0.0x
P/E Ratio0.0x
P/S RatioIs MJNA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MJNA income statement (TTM) | |
|---|---|
| Revenue | US$58.98m |
| Cost of Revenue | US$12.50m |
| Gross Profit | US$46.48m |
| Other Expenses | US$37.69m |
| Earnings | US$8.80m |
Last Reported Earnings
Jun 30, 2020
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MJNA perform over the long term?
See historical performance and comparison